Factors Associated with HIV Status Disclosure and Its Effect on Treatment Adherence and Quality of Life Among Children 6-17 Years on Antiretroviral Therapy in Southern Highlands Zone, Tanzania: Unmatched Case Control Study

Overview

Journal Int J Pediatr

Publisher Wiley

Specialty Pediatrics

Date 2018 Jul 27

PMID 30046314

Citations 16

Authors

Regina Edward Bulali

Stephen Matthew Kibusi

Bonaventura C T Mpondo

Affiliations

Soon will be listed here.

Abstract

Background: The World Health Organization (WHO) recommends that children should be informed of their HIV status at ages 6 to 12 years and full disclosure of HIV and AIDS be offered in a caring and supportive manner at about 8 to 10 years. The objective of this study was to determine factors associated with HIV status disclosure and its effect on treatment adherence and health-related quality of life among children between 6 and 17 years of age living with HIV/AIDS in the Southern Highlands Zone, Tanzania, 2017.

Methods: A hospital based unmatched case control study was conducted between April and September 2017. A total of 309 children between 6 and 17 years on ART for at least six months were enrolled in this study. Simple random sampling was employed in selecting the children from existing treatment registers. Data were collected using a structured questionnaire which included the WHO Quality of Life standard tool (WHOQOL-BREF 2012 tool) and treatment adherence manual. Multiple logistic regression was used to test for the independent effect of HIV status disclosure on treatment adherence and quality of life at p value less than 0.05.

Results: Out of 309 children, only 102 (33%) had their HIV status disclosed to them. The mean age at HIV status disclosure was 12.39 (SD=3.015). HIV status disclosure was high among girls (51%), children aged 10-13 years (48.3%), and those living with their biological parents (59.8%). After adjusting for confounders, being aged between 10-13 and 14-17 years was associated with HIV status disclosure (AOR 19.178, p<0.05 and AOR=65.755, p<0.001, respectively). HIV status disclosure was associated with ART adherence (AOR=8.173, p<0.05) and increased the odds of having good quality of life (AOR=3.283, p<0.001).

Conclusions: HIV status disclosure significantly improved adherence to treatment and quality of life among children living with HIV/AIDS.

Citing Articles

Factors associated with caregiver compliance to an HIV disclosure intervention and its effect on HIV and mental health outcomes among children living with HIV: instrumental variable-based analysis of a cluster randomized trial in Eldoret, Kenya.

Magill E, Nyandiko W, Baum A, Aluoch J, Chory A, Ashimoshi C Front Public Health. 2023; 11:1150744.

PMID: 37213654 PMC: 10196043. DOI: 10.3389/fpubh.2023.1150744.

Barriers and facilitators to anti-retroviral therapy adherence among adolescents aged 10 to 19 years living with HIV in sub-Saharan Africa: A mixed-methods systematic review and meta-analysis.

Hlophe L, Tamuzi J, Shumba C, Nyasulu P PLoS One. 2023; 18(5):e0276411.

PMID: 37200399 PMC: 10194875. DOI: 10.1371/journal.pone.0276411.

Disclosure of HIV status and associated clinical outcomes of children and adolescents living with HIV in Asia.

Sornillo J, Ditangco R, Lumbiganon P, Vu T, Le O, Truong K AIDS Care. 2023; 35(12):1928-1937.

PMID: 36794343 PMC: 10425563. DOI: 10.1080/09540121.2023.2176424.

Lessons Learned from the Impact of HIV Status Disclosure to Children after First-Line Antiretroviral Treatment Failure in Kinshasa, DR Congo.

Kitetele F, Lelo G, Akele C, Lelo P, Aketi L, Mafuta E Children (Basel). 2022; 9(12).

PMID: 36553398 PMC: 9777424. DOI: 10.3390/children9121955.

Acceptance of Index Case HIV Testing and Its Associated Factors Among HIV/AIDS Clients on ART Follow-Up in West Ethiopia: A Multi-Centered Facility-Based Cross-Sectional Study.

Edosa M, Merdassa E, Turi E HIV AIDS (Auckl). 2022; 14:451-460.

PMID: 36199377 PMC: 9528797. DOI: 10.2147/HIV.S372795.

References

Odiachi A . The Impact of Disclosure on Health and Related Outcomes in Human Immunodeficiency Virus-Infected Children: A Literature Review. Front Public Health. 2017; 5:231. PMC: 5582203. DOI: 10.3389/fpubh.2017.00231. View

Negese D, Addis K, Awoke A, Birhanu Z, Muluye D, Yifru S . HIV-Positive Status Disclosure and Associated Factors among Children in North Gondar, Northwest Ethiopia. ISRN AIDS. 2013; 2012:485720. PMC: 3767337. DOI: 10.5402/2012/485720. View

Butler A, Williams P, Howland L, Storm D, Hutton N, Seage 3rd G . Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection. Pediatrics. 2009; 123(3):935-43. PMC: 2697844. DOI: 10.1542/peds.2008-1290. View

Vreeman R, Scanlon M, Mwangi A, Turissini M, Ayaya S, Tenge C . A cross-sectional study of disclosure of HIV status to children and adolescents in western Kenya. PLoS One. 2014; 9(1):e86616. PMC: 3903588. DOI: 10.1371/journal.pone.0086616. View

Mandalazi P, Bandawe C, Umar E . HIV Disclosure: Parental dilemma in informing HIV infected Children about their HIV Status in Malawi. Malawi Med J. 2015; 26(4):101-4. PMC: 4325342. View

Mumburi L, Hamel B, Philemon R, Kapanda G, Msuya L . Factors associated with HIV-status disclosure to HIV-infected children receiving care at Kilimanjaro Christian Medical Centre in Moshi, Tanzania. Pan Afr Med J. 2014; 18:50. PMC: 4215360. DOI: 10.11604/pamj.2014.18.50.2307. View

Ubesie A, Iloh K, Emodi I, Ibeziako N, Obumneme-Anyim I, Iloh O . HIV status disclosure rate and reasons for non-disclosure among infected children and adolescents in Enugu, southeast Nigeria. SAHARA J. 2016; 13(1):136-41. PMC: 5642443. DOI: 10.1080/17290376.2016.1226942. View

Nichols J, Steinmetz A, Paintsil E . Impact of HIV-Status Disclosure on Adherence to Antiretroviral Therapy Among HIV-Infected Children in Resource-Limited Settings: A Systematic Review. AIDS Behav. 2016; 21(1):59-69. DOI: 10.1007/s10461-016-1481-z. View

Pinzon-Iregui M, Beck-Sague C, Malow R . Disclosure of their HIV status to infected children: a review of the literature. J Trop Pediatr. 2012; 59(2):84-9. PMC: 3693505. DOI: 10.1093/tropej/fms052. View

10.

Cluver L, Hodes R, Toska E, Kidia K, Orkin F, Sherr L . 'HIV is like a tsotsi. ARVs are your guns': associations between HIV-disclosure and adherence to antiretroviral treatment among adolescents in South Africa. AIDS. 2015; 29 Suppl 1:S57-65. DOI: 10.1097/QAD.0000000000000695. View

11.

Polisset J, Ametonou F, Arrive E, Aho A, Perez F . Correlates of adherence to antiretroviral therapy in HIV-infected children in Lomé, Togo, West Africa. AIDS Behav. 2008; 13(1):23-32. DOI: 10.1007/s10461-008-9437-6. View

12.

Dachew B, Tesfahunegn T, Birhanu A . Adherence to highly active antiretroviral therapy and associated factors among children at the University of Gondar Hospital and Gondar Poly Clinic, Northwest Ethiopia: a cross-sectional institutional based study. BMC Public Health. 2014; 14:875. PMC: 4158084. DOI: 10.1186/1471-2458-14-875. View

13.

Biressaw S, Abegaz W, Abebe M, Taye W, Belay M . Adherence to Antiretroviral Therapy and associated factors among HIV infected children in Ethiopia: unannounced home-based pill count versus caregivers' report. BMC Pediatr. 2013; 13:132. PMC: 3766076. DOI: 10.1186/1471-2431-13-132. View

14.

Bikaako-Kajura W, Luyirika E, Purcell D, Downing J, Kaharuza F, Mermin J . Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav. 2006; 10(4 Suppl):S85-93. DOI: 10.1007/s10461-006-9141-3. View

15.

Kenu E, Obo-Akwa A, Nuamah G, Brefo A, Sam M, Lartey M . Knowledge and disclosure of HIV status among adolescents and young adults attending an adolescent HIV clinic in Accra, Ghana. BMC Res Notes. 2014; 7:844. PMC: 4256736. DOI: 10.1186/1756-0500-7-844. View

16.

Vreeman R, Gramelspacher A, Gisore P, Scanlon M, Nyandiko W . Disclosure of HIV status to children in resource-limited settings: a systematic review. J Int AIDS Soc. 2013; 16:18466. PMC: 3665848. DOI: 10.7448/IAS.16.1.18466. View

17.

Tadesse B, Foster B, Berhan Y . Cross Sectional Characterization of Factors Associated with Pediatric HIV Status Disclosure in Southern Ethiopia. PLoS One. 2015; 10(7):e0132691. PMC: 4500496. DOI: 10.1371/journal.pone.0132691. View

18.

Kim M, Mazenga A, Yu X, Ahmed S, Paul M, Kazembe P . High self-reported non-adherence to antiretroviral therapy amongst adolescents living with HIV in Malawi: barriers and associated factors. J Int AIDS Soc. 2017; 20(1):21437. PMC: 5515061. DOI: 10.7448/IAS.20.1.21437. View

19.

Biadgilign S, Deribew A, Amberbir A, Escudero H, Deribe K . Factors associated with HIV/AIDS diagnostic disclosure to HIV infected children receiving HAART: a multi-center study in Addis Ababa, Ethiopia. PLoS One. 2011; 6(3):e17572. PMC: 3061859. DOI: 10.1371/journal.pone.0017572. View

20.

Arage G, Tessema G, Kassa H . Adherence to antiretroviral therapy and its associated factors among children at South Wollo Zone Hospitals, Northeast Ethiopia: a cross-sectional study. BMC Public Health. 2014; 14:365. PMC: 4002537. DOI: 10.1186/1471-2458-14-365. View